COLIN BILSKI: Open Payments
NPI 1992217475 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 6 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $769 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| Zimmer Biomet Holdings, Inc. | 1 | $120 |
| Neurelis, Inc. | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $118 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
Products named: AIRSUPRA, Persona, VALTOCO, JARDIANCE, UZEDY.
Industry payments across OH — which companies pay providers there.
